A5005373482- Head and Neck Cancer Studies
- Head and Neck Surgical Oncology
- Nonmelanoma Skin Cancer Studies
- Ear and Head Tumors
- Dysphagia Assessment and Management
- Salivary Gland Tumors Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Oral health in cancer treatment
- Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Advanced Radiotherapy Techniques
- Brain Metastases and Treatment
- Cancer and Skin Lesions
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cutaneous Melanoma Detection and Management
- Management of metastatic bone disease
- Cervical Cancer and HPV Research
- Esophageal and GI Pathology
- Esophageal Cancer Research and Treatment
- Tracheal and airway disorders
- Polyomavirus and related diseases
- Radiomics and Machine Learning in Medical Imaging
- CAR-T cell therapy research
- Cutaneous lymphoproliferative disorders research
Peter MacCallum Cancer Centre
2001-2025
Princess Alexandra Hospital
2015-2024
The University of Queensland
2015-2024
The University of Melbourne
2006-2024
Royal Brisbane and Women's Hospital
2018-2023
Regeneron (United States)
2023
Hudson Institute
2023
Cancer Services
2011-2021
University of Louisville Hospital
2021
Queensland Health
2011-2020
PurposeThe objective of this project was to define consensus guidelines for delineating organs at risk (OARs) head and neck radiotherapy routine daily practice research purposes.MethodsConsensus were formulated based on in-depth discussions a panel European, North American, Asian Australian radiation oncologists.ResultsTwenty-five OARs in the region defined with concise description their main anatomic boundaries. The Supplemental material provides an atlas guidelines, projected 1 mm axial...
Purpose To determine the association between tumor hypoxia, treatment regimen, and locoregional failure (LRF) in patients with stage III or IV squamous cell carcinoma of head neck randomly assigned to radiotherapy (70 Gy 35 fractions over 7 weeks) plus either tirapazamine cisplatin weeks 1, 4, alone 2 3 (TPZ/CIS) infusional fluorouracil during 6 (chemoboost). Patients Methods Forty-five were enrolled onto a hypoxic imaging substudy larger randomized trial. Pretreatment midtreatment [ 18...
Because of the unprecedented disruption health care services caused by COVID-19 pandemic, American Society Radiation Oncology (ASTRO) and European for Radiotherapy (ESTRO) identified an urgent need to issue practice recommendations radiation oncologists treating head neck cancer (HNC) in a time limited resources heightened risk patients staff.
Background. This study evaluates the utility of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in patients with a node-positive mucosal head and neck squamous cell carcinoma who achieved complete response at primary site but had residual mass 8 weeks or more after definitive (chemo)radiotherapy. Methods. Between October 1996 July 2002, 39 eligible were identified. The reference PET scan was performed median 12 (range, 8–32 weeks) treatment. Results. showed no metabolic...
Abstract Background Percutaneous endoscopic gastrostomy (PEG) tubes have largely replaced nasogastric (NGTs) for nutritional support of patients with head and neck cancer undergoing curative (chemo) radiotherapy without any good scientific basis. Methods A prospective study was conducted to compare PEG NGTs in terms outcomes, complications, patient satisfaction, cost. Results There were 32 73 NGT patients. sustained significantly less weight loss at 6 weeks post‐treatment (median 0.8 kg gain...
The purpose of this study was to present our prospectively evaluated positron emission tomography (PET)-directed policy for managing the neck in node-positive head and squamous cell carcinoma (N+HNSCC) after definitive radiotherapy (RT) with or without concurrent systemic therapy.One hundred twelve consecutive patients who achieved a complete response at primary site underwent 12-week posttherapy nodal assessment PET diagnostic CT. Patients an equivocal repeat 4 6 weeks later. residual CT...
Stereotactic body radiotherapy (SBRT) is often used to treat patients with oligometastases (OM). Yet, patterns of SBRT practice for OM are unknown. Therefore, we surveyed radiation oncologists internationally, understand how and when OM.A 25-question survey was distributed oncologists. Respondents using were asked long they have been treating OM, number treated, organs primary reason use, doses used, future intentions. not reasons why intentions adoption. Data analyzed anonymously.We...
The prevalence and severity of dysphagia in people treated non-surgically for primary head neck cancer (HNC) is well documented. However, few studies have looked beyond the physiological impairment to explore lived experience post-treatment period HNC. current study adopted a person-centred, qualitative approach describe experiences living with months years following non-surgical treatment Using maximum variation sampling, 24 participants who had undergone radiotherapy HNC were recruited....
Abstract Background. Sinonasal undifferentiated carcinoma (SNUC) is an uncommon malignancy associated with poor prognosis. The optimal treatment approach for SNUC has not been established was performed. Methods. A retrospective review of all patients seen at the Peter MacCallum Cancer Centre over a 12‐year period. Results. Ten were identified, nine having locally advanced disease (T4). Seven treated three cycles platinum and 5‐fluorouracil followed by radiation two concurrent platinum. In...